Diabetes, Active Disease, and Afternoon Serum Cortisol Levels Predict Cushing’s Disease Mortality: A Cohort Study
Open accessThe DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.
Abstract
Context: Cushing’s disease (CD) is a life-threating disease, with increased mortality in comparison with the general population. Objective: This study aimed to evaluate standardized mortality ratios (SMRs) in CD patients. We also analyzed independent risk factors related to increased mortality. Design: We conducted a longitudinal cohort study in a 3rd level specialty center, from 1979 to 2018, in patients with CD. Results: From 1375 cases with a pathology diagnosis of pituitary adenoma, 191 cases had the confirmed diagnosis of CD (14%). A total of 172 patients completed follow-up, with a mean age at diagnosis of 33 ± 11 years, female predominance (n = 154, 89.5%), majority of them with microadenoma (n = 136, 79%), and a median follow-up of 7.5 years (2.4–15). Eighteen patients (10.5%) died, 8 of them (44%) were with active CD, 8 (44%) were under remission, and 2 (11%) were under disease control. Estimated all-cause SMR = 3.1, 95% confidence interval (CI) 1.9–4.8, P < 0.001. Cardiovascular disease was the main cause of death (SMR = 4.2, 1.5–9.3, P = 0.01). Multivariate Cox regression models adjusted for potential cofounders showed that diabetes (HR = 5.2, IC 95% 1.8–15.4, P = 0.002), high cortisol levels after 1600 hours at diagnosis (3.4, 2.3–7.0, P = 0.02), and active CD (7.5, 3.8–17.3, P = 0.003) significantly increased the risk of mortality. Conclusions: Main cause of CD mortality was cardiovascular disease. Main risk factors for mortality were uncontrolled diabetes, persistently high cortisol levels after 1600 hours at diagnosis, and active disease at last follow-up.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The diagnosis of Cushing's syndrome: an Endocrine Society Clinical Practice Guideline.
Nieman, L. K., Biller, B. M. K., Findling, J. W., Newell-Price, J., Savage, M. O., Stewart, P. M., & Montori, V. M. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-0125 · Cited by 2,718
Treatment of Cushing's syndrome: an Endocrine Society clinical practice guideline
Nieman, L. K., Biller, B. M. K., Findling, J. W., Murad, M. H., Newell-Price, J., Savage, M. O., & Tabarin, A. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-1818 · Cited by 1,270
Morbidity and mortality in Cushing's disease: an epidemiological approach.
Etxabe, J., & Vazquez, J. A. (1994) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1994.tb02486.x · Cited by 622
Characterization of the normal temporal pattern of plasma corticosteroid levels.
KRIEGER, D. T., ALLEN, W., RIZZO, F., & KRIEGER, H. P. (1971) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-32-2-266 · Cited by 549
The Functional and Clinical Significance of the 24-Hour Rhythm of Circulating Glucocorticoids
Oster, H., Challet, E., Ott, V., Arvat, E., de Kloet, E. R., Dijk, D.-J., Lightman, S., Vgontzas, A., & Van Cauter, E. (2017) · Endocrine Reviews · doi:10.1210/er.2015-1080 · Cited by 548
Multisystem morbidity and mortality in Cushing’s syndrome: a cohort study
Dekkers, O. M., Horváth-Puhó, E., Jørgensen, J. O. L., Cannegieter, S. C., Ehrenstein, V., Vandenbroucke, J. P., Pereira, A. M., & Sørensen, H. T. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-3582 · Cited by 419
Clayton, R. N., Jones, P. W., Reulen, R. C., Stewart, P. M., Hassan-Smith, Z. K., Ntali, G., Karavitaki, N., Dekkers, O. M., Pereira, A. M., Bolland, M., et al. (2016) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(16)30005-5 · Cited by 208
Putignano, P., Toja, P., Dubini, A., Giraldi, F. P., Corsello, S. M., & Cavagnini, F. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030312 · Cited by 182
Midnight salivary cortisol for the initial diagnosis of Cushing's syndrome of various causes.
Yaneva, M., Mosnier-Pudar, H., Dugué, M.-A., Grabar, S., Fulla, Y., & Bertagna, X. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031790 · Cited by 179
Outcome of Cushing's disease following transsphenoidal surgery in a single center over 20 years
Hassan-Smith, Z. K., Sherlock, M., Reulen, R. C., Arlt, W., Ayuk, J., Toogood, A. A., Cooper, M. S., Johnson, A. P., & Stewart, P. M. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-2957 · Cited by 153
Mortality in Cushing's syndrome: data from 386 patients from a single tertiary referral center
Yaneva, M., Kalinov, K., & Zacharieva, S. (2013) · European Journal of Endocrinology · doi:10.1530/eje-13-0320 · Cited by 93
Fleseriu, M., Hamrahian, A. H., Hoffman, A. R., Kelly, D. F., & Katznelson, L. (2016) · Endocrine Practice · doi:10.4158/ep161512.dscr · Cited by 68
Hypercortisolemia Recurrence in Cushing’s disease; a diagnostic challenge
Hinojosa-Amaya, J. M., Varlamov, E. V., McCartney, S., & Fleseriu, M. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00740 · Cited by 45
Self-citation
Research works printed but not linked: 25
- Suarez, 2020, Hypercoagulability in Cushing syndrome, prevalence of thrombotic events: a large, single-center, retrospective study, J Endocr Soc., 4, bvz033, 10.1210/jendso/bvz033 · DOI · Paper page
- Wagner, 2018, Hypercoagulability and risk of venous thromboembolic events in endogenous Cushing’s syndrome: a systematic meta-analysis, Front Endocrinol (Lausanne)., 28, 1
- Ferraù, 2015, Metabolic comorbidities in Cushing’s syndrome, Eur J Endocrinol., 173, M133, 10.1530/EJE-15-0354 · DOI · Paper page
- Swearingen, 1999, Long-term mortality after transsphenoidal surgery for Cushing disease, Ann Intern Med., 130, 821, 10.7326/0003-4819-130-10-199905180-00015 · DOI · Paper page
- Alexandraki, 2013, Long-term remission and recurrence rates in Cushing’s disease: predictive factors in a single-centre study, Eur J Endocrinol., 168, 639, 10.1530/EJE-12-0921 · DOI · Paper page
- Yap, 2002, Undetectable postoperative cortisol does not always predict long-term remission in Cushing’s disease: a single centre audit, Clin Endocrinol (Oxf)., 56, 25, 10.1046/j.0300-0664.2001.01444.x · DOI · Paper page
- van Haalen, 2015, Management of endocrine disease: mortality remains increased in Cushing’s disease despite biochemical remission: a systematic review and meta-analysis, Eur J Endocrinol., 172, R143, 10.1530/EJE-14-0556 · DOI · Paper page
- Lambert, 2013, Predictors of mortality and long-term outcomes in treated Cushing’s disease: a study of 346 patients, J Clin Endocrinol Metab., 98, 1022, 10.1210/jc.2012-2893 · DOI · Paper page
- Colao, 1999, Persistence of increased cardiovascular risk in patients with Cushing’s disease after five years of successful cure, J Clin Endocrinol Metab., 84, 2664
- Loriaux, 2017, Diagnosis and differential diagnosis of Cushing’s syndrome, New Engl J Med., 376, 1451, 10.1056/NEJMra1505550 · DOI · Paper page
- van den Bogaert, 1999, The continuous 7-hour intravenous dexamethasone suppression test in the differential diagnosis of ACTH-dependent Cushing’s syndrome, Clin Endocrinol (Oxf)., 51, 193, 10.1046/j.1365-2265.1999.00759.x · DOI
- Boscaro, 2009, Approach to the patient with possible Cushing’s syndrome, J Clin Endocrinol Metab., 94, 3121, 10.1210/jc.2009-0612 · DOI · Paper page
- Liddle, 1960, Tests of pituitary-adrenal suppressibility in the diagnosis of Cushing’s syndrome, J Clin Endocrinol Metab., 20, 1539, 10.1210/jcem-20-12-1539 · DOI · Paper page
- Boscaro, 1992, Selective venous sampling in the differential diagnosis of ACTH-dependent Cushing’s syndrome, Neuroendocrinology., 55, 264, 10.1159/000126124 · DOI
- Pikkarainen, 1999, The survival and well-being of patients treated for Cushing’s syndrome, J Intern Med., 245, 463, 10.1046/j.1365-2796.1999.00483.x · DOI · Paper page
- Jagannathan, 2007, Evaluation and management of Cushing syndrome in cases of negative sellar magnetic resonance imaging, Neurosurg Focus., 23, 1, 10.3171/foc.2007.23.3.4 · doi:10.3171/foc.2007.23.3.4
- Barber, 2010, Nelson’s syndrome, Eur J Endocrinol., 163, 495, 10.1530/EJE-10-0466 · DOI
- Graversen, 2012, Mortality in Cushing’s syndrome: a systematic review and meta-analysis, Eur J Intern Med., 23, 278, 10.1016/j.ejim.2011.10.013 · DOI
- Ljubijankić, 2008, Daily fluctuation of cortisol in the saliva and serum of healthy persons, Bosn J Basic Med Sci., 8, 110, 10.17305/bjbms.2008.2962 · DOI
- Papanicolaou, 1998, A single midnight serum cortisol measurement distinguishes Cushing’s syndrome from pseudo-Cushing states, J Clin Endocrinol Metab., 83, 1163
- Carroll, 2010, The diagnosis of Cushing’s syndrome, Rev Endocr Metab Disord., 11, 147, 10.1007/s11154-010-9143-3 · DOI
- Espinosa-de-Los-Monteros, 2017, Long-term outcome of the different treatment alternatives for recurrent and persistent Cushing disease, Endocr Pract., 23, 759, 10.4158/EP171756.OR · DOI
- Patil, 2008, Outcomes after repeat transsphenoidal surgery for recurrent Cushing’s disease, Neurosurgery., 63, 266, 10.1227/01.NEU.0000313117.35824.9F · DOI · Paper page
- Ironside, 2018, Earlier post-operative hypocortisolemia may predict durable remission from Cushing’s disease, Eur J Endocrinol., 178, 255, 10.1530/EJE-17-0873 · DOI
- Yamada, 2015, Therapeutic outcomes in patients undergoing surgery after diagnosis of Cushing’s disease: a single-center study, Endocr J., 62, 1115, 10.1507/endocrj.15-0463 · DOI
Cited by
Consensus on diagnosis and management of Cushing's disease: a guideline update
Fleseriu, M., Auchus, R., Bancos, I., Ben-Shlomo, A., Bertherat, J., Biermasz, N. R., Boguszewski, C. L., Bronstein, M. D., Buchfelder, M., Carmichael, J. D., et al. (2021) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(21)00235-7 · Cited by 953
Clinical Biology of the Pituitary Adenoma
Melmed, S., Kaiser, U. B., Lopes, M. B., Bertherat, J., Syro, L. V., Raverot, G., Reincke, M., Johannsson, G., Beckers, A., Fleseriu, M., et al. (2022) · Endocrine Reviews · doi:10.1210/endrev/bnac010 · Cited by 321
Pelsma, I. C. M., Fassnacht, M., Tsagarakis, S., Terzolo, M., Tabarin, A., Sahdev, A., Newell-Price, J., Marina, L., Lorenz, K., Bancos, I., et al. (2023) · European Journal of Endocrinology · doi:10.1093/ejendo/lvad134 · Cited by 130
“3 9-14 However, the association between MACS and these comorbidities potentially attributable to cortisol is uncertain, and the causality is disputed.”
Long-term consequences of Cushing syndrome: a systematic literature review
Puglisi, S., Perini, A. M. E., Botto, C., Oliva, F., & Terzolo, M. (2024) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgad453 · Cited by 53
Hamidi, O., St-Jean, M., Lacroix, A., & Bancos, I. (2026) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgag095 · Cited by 5
Metadata
- Authors
- Roldán-Sarmiento, P., Lam-Chung, C. E., Hinojosa-Amaya, J. M., Morales-García, M., Guillén-Placencia, M. F., Pérez-Flores, G. E., León-Suárez, A., León-Domínguez, J., Balbuena-Álvarez, S., Nava de la Vega, A., Pérez-Guzmán, C. M., Gómez-Sámano, M. Á., Enríquez-Estrada, V., Gómez-Pérez, F. J., & Cuevas-Ramos, D.
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2020-10-28
- Volume
- 106
- Issue
- 1
- Pages
- e103-e111
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W3097439661
- Cited by
- 25
- References
- 13
- FWCI
- 2.87
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.